Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer

Clinical trial NCT00514072 · UNKNOWN

Trial details

NCT number: NCT00514072
Sponsor: Kael-GemVax Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2007-03-01
Primary completion: 2012-09-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.